Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
3.970
+0.140 (3.66%)
Jan 28, 2026, 1:42 PM EST - Market open
Nuwellis Revenue
Nuwellis had revenue of $2.22M in the quarter ending September 30, 2025, a decrease of -6.34%. This brings the company's revenue in the last twelve months to $8.17M, down -8.93% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.
Revenue (ttm)
$8.17M
Revenue Growth
-8.93%
P/S Ratio
0.14
Revenue / Employee
$214,947
Employees
38
Market Cap
6.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
| Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
| Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
| Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
| Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
| Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
| Dec 31, 2013 | 59.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| STRATA Skin Sciences | 30.98M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| Intelligent Bio Solutions | 3.29M |
| Tenon Medical | 3.23M |
| iTonic Holdings | 305.22K |
| Nexalin Technology | 156.93K |
| Profusa | 75.00K |
NUWE News
- 1 day ago - Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare - Benzinga
- 4 days ago - Nuwellis Announces Changes to Board of Directors - GlobeNewsWire
- 22 days ago - Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy - GlobeNewsWire
- 7 weeks ago - Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings - GlobeNewsWire
- 7 weeks ago - Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. - GlobeNewsWire
- 2 months ago - Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 2 months ago - Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum - GlobeNewsWire
- 2 months ago - Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology - GlobeNewsWire